Weber-Matthiesen K, Müller-Hermelink A, Deerberg J, Scherthan H, Schlegelberger B, Grote W
Institut für Humangenetik, Klinikum, Christian-Albrechts-Universität, Kiel, Germany.
J Histochem Cytochem. 1993 Nov;41(11):1641-4. doi: 10.1177/41.11.7691932.
We describe a method that enables detection and immunophenotypical characterization of distinct subpopulations within a cytogenetically defined tumor clone. Coexisting normal cells do not hinder microscopic evaluation because they can be distinguished from cytogenetically aberrant tumor cells. This is also true when normal and neoplastic cells cannot be clearly distinguished by cytology or immunohistochemistry, i.e., if both constituents have similar immunophenotypes and morphology. The method is based on fluorescence double staining for two different antigens combined with interphase cytogenetic analysis. It is referred to as "Fluorescence immunophenotyping and Interphase Cytogenetics as a Tool for Investigation of Neoplasms (FICTION)." In a case of follicular lymphoma we demonstrate that FICTION can differentiate bcl-2-positive malignant and non-malignant cells and can verify the presence of bcl-2-positive but cytogenetically inconspicuous T-lymphocytes.
我们描述了一种方法,该方法能够对细胞遗传学定义的肿瘤克隆内不同亚群进行检测和免疫表型特征分析。共存的正常细胞不会妨碍显微镜评估,因为它们可与细胞遗传学异常的肿瘤细胞区分开来。当正常细胞和肿瘤细胞无法通过细胞学或免疫组织化学清楚区分时,即如果两者成分具有相似的免疫表型和形态时,情况也是如此。该方法基于对两种不同抗原的荧光双重染色并结合间期细胞遗传学分析。它被称为“荧光免疫表型分析和间期细胞遗传学作为肿瘤研究工具(FICTION)”。在一例滤泡性淋巴瘤中,我们证明FICTION能够区分bcl-2阳性的恶性和非恶性细胞,并能证实存在bcl-2阳性但细胞遗传学不明显的T淋巴细胞。